Release Date: 27/07/15 08:28 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 107.88KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%